Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A

Abstract The epithelial–mesenchymal transition (EMT) imparts properties of cancer stem-like cells, including resistance to frequently used chemotherapies, necessitating the identification of molecules that induce cell death specifically in stem-like cells with EMT properties. Herein, we demonstrate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keighley N. Reisenauer, Yongfeng Tao, Provas Das, Shuxuan Song, Haleigh Svatek, Saawan D. Patel, Sheridan Mikhail, Alec Ingros, Peter Sheesley, Marco Masi, Angela Boari, Antonio Evidente, Alexander Kornienko, Daniel Romo, Joseph Taube
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d75b28ec027d450f93ccf40375922980
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d75b28ec027d450f93ccf40375922980
record_format dspace
spelling oai:doaj.org-article:d75b28ec027d450f93ccf403759229802021-12-02T15:45:26ZEpithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A10.1038/s41598-021-89923-92045-2322https://doaj.org/article/d75b28ec027d450f93ccf403759229802021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89923-9https://doaj.org/toc/2045-2322Abstract The epithelial–mesenchymal transition (EMT) imparts properties of cancer stem-like cells, including resistance to frequently used chemotherapies, necessitating the identification of molecules that induce cell death specifically in stem-like cells with EMT properties. Herein, we demonstrate that breast cancer cells enriched for EMT features are more sensitive to cytotoxicity induced by ophiobolin A (OpA), a sesterterpenoid natural product. Using a model of experimentally induced EMT in human mammary epithelial (HMLE) cells, we show that EMT is both necessary and sufficient for OpA sensitivity. Moreover prolonged, sub-cytotoxic exposure to OpA is sufficient to suppress EMT-imparted CSC features including sphere formation and resistance to doxorubicin. In vivo growth of CSC-rich mammary cell tumors, is suppressed by OpA treatment. These data identify a driver of EMT-driven cytotoxicity with significant potential for use either in combination with standard chemotherapy or for tumors enriched for EMT features.Keighley N. ReisenauerYongfeng TaoProvas DasShuxuan SongHaleigh SvatekSaawan D. PatelSheridan MikhailAlec IngrosPeter SheesleyMarco MasiAngela BoariAntonio EvidenteAlexander KornienkoDaniel RomoJoseph TaubeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Keighley N. Reisenauer
Yongfeng Tao
Provas Das
Shuxuan Song
Haleigh Svatek
Saawan D. Patel
Sheridan Mikhail
Alec Ingros
Peter Sheesley
Marco Masi
Angela Boari
Antonio Evidente
Alexander Kornienko
Daniel Romo
Joseph Taube
Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A
description Abstract The epithelial–mesenchymal transition (EMT) imparts properties of cancer stem-like cells, including resistance to frequently used chemotherapies, necessitating the identification of molecules that induce cell death specifically in stem-like cells with EMT properties. Herein, we demonstrate that breast cancer cells enriched for EMT features are more sensitive to cytotoxicity induced by ophiobolin A (OpA), a sesterterpenoid natural product. Using a model of experimentally induced EMT in human mammary epithelial (HMLE) cells, we show that EMT is both necessary and sufficient for OpA sensitivity. Moreover prolonged, sub-cytotoxic exposure to OpA is sufficient to suppress EMT-imparted CSC features including sphere formation and resistance to doxorubicin. In vivo growth of CSC-rich mammary cell tumors, is suppressed by OpA treatment. These data identify a driver of EMT-driven cytotoxicity with significant potential for use either in combination with standard chemotherapy or for tumors enriched for EMT features.
format article
author Keighley N. Reisenauer
Yongfeng Tao
Provas Das
Shuxuan Song
Haleigh Svatek
Saawan D. Patel
Sheridan Mikhail
Alec Ingros
Peter Sheesley
Marco Masi
Angela Boari
Antonio Evidente
Alexander Kornienko
Daniel Romo
Joseph Taube
author_facet Keighley N. Reisenauer
Yongfeng Tao
Provas Das
Shuxuan Song
Haleigh Svatek
Saawan D. Patel
Sheridan Mikhail
Alec Ingros
Peter Sheesley
Marco Masi
Angela Boari
Antonio Evidente
Alexander Kornienko
Daniel Romo
Joseph Taube
author_sort Keighley N. Reisenauer
title Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A
title_short Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A
title_full Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A
title_fullStr Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A
title_full_unstemmed Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A
title_sort epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin a
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d75b28ec027d450f93ccf40375922980
work_keys_str_mv AT keighleynreisenauer epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT yongfengtao epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT provasdas epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT shuxuansong epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT haleighsvatek epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT saawandpatel epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT sheridanmikhail epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT alecingros epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT petersheesley epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT marcomasi epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT angelaboari epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT antonioevidente epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT alexanderkornienko epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT danielromo epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
AT josephtaube epithelialmesenchymaltransitionsensitizesbreastcancercellstocelldeathviathefungusderivedsesterterpenoidophiobolina
_version_ 1718385778783944704